Stock listing

BCBA:NTRAD Natera, Inc. Acciones

Argentine listing (BCBA) of Natera, Inc. · home listing NASDAQ:NTRA

Follow Natera, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:NTRA

$394.75 USD -0.90 (-0.2%)

Close on Oct 14, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NTRA

Natera, Inc. logo
Ticker
BCBA:NTRAD
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
BCBA
Currency
USD

What changed lately

Calls

Replays

  • Natera (NASDAQ:NTRA) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 4:30 PM ET

    Watch Transcript

  • Natera (NASDAQ:NTRA) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 4:30 PM ET

    Watch Transcript

  • Natera (NASDAQ:NTRA) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Natera’s Signatera™ MRD Test Named to TIME’s List of the Best Inventions of 2026

Oct 15, 2026

Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer

Oct 13, 2026

FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay

Oct 9, 2026

Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma

Oct 7, 2026

New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists

Oct 6, 2026

Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Oct 5, 2026

Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

Sep 22, 2026

Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM

Sep 18, 2026

New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma

Sep 1, 2026

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer

Aug 28, 2026

All Natera, Inc. news

Decks

Natera, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
81 in the last 12 months · 328 in all · newest Oct 15, 2026 · oldest 2019
Calls
19 calls with a replay · 19 with a transcript · latest Aug 6, 2026
Decks
57 decks · latest Aug 6, 2026

Where Natera, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NTRA · Home listingNASDAQUnited StatesUSD
gettex:45EgettexGermanyEUR
Tradegate:45ETradegateGermanyEUR
BMV:NTRABMVMexicoMXN
BIVA:NTRABIVAMexicoMXN
BOATS:NTRABOATSUnited StatesUSD
BX Swiss:NTRABX SwissSwitzerlandCHF
Dusseldorf:45EDusseldorfGermanyEUR
Frankfurt:45EFrankfurtGermanyEUR
Munich:45EMunichGermanyEUR
BCBA:NTRABCBAArgentinaARS
BCBA:NTRA.CIBCBAArgentinaARS
BCBA:NTRAD · This pageBCBAArgentinaUSD
Hamburg:45EHamburgGermanyEUR
Hanover:45EHanoverGermanyEUR
Lang & Schwarz:A14VPJLang & SchwarzGermanyEUR
LS Exchange:A14VPJLS ExchangeGermanyEUR
Xetra:45EXetraGermanyEUR

Log in to ask 6ix AI your own questions about Natera, Inc.